2024 Update of the Asia‐Pacific League of Associations for Rheumatology ( APLAR ) Recommendations for Rheumatoid Arthritis Management
International Journal of Rheumatic Diseases · 2026
DOI: 10.1111/1756-185x.70752 ↗Kurz gefasst
Leitlinie in der Zeitschrift International Journal of Rheumatic Diseases, 2026. Verfasst von Kunihiro Yamaoka und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Kitasato University School of Medicine, Sagamihara, Japan. Hauptthemen laut MEDLINE: Antirheumatic Agents, Arthritis, Rheumatoid, Rheumatology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GlaxoSmithKline, AbbVie.
Abstract (Originalsprache)
Aim
To update the Asia‐Pacific League of Associations for Rheumatology (APLAR) treatment recommendations for rheumatoid arthritis (RA) by incorporating new evidence and reassessing the validity of previous guidance: Methods A literature search for relevant publications from January 2018 to August 2023 was conducted, supplemented by earlier studies where relevant. Recommendations were formulated based on this evidence and refined through a modified‐Delphi process during a series of online meetings. The quality of evidence and strength of recommendations were assessed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach.
Results
This update comprises 14 statements that achieved consensus during the meetings. Topics covered include measurement of disease activity and treatment response, the use of conventional synthetic disease‐modifying antirheumatic drugs (csDMARDs), the use of targeted therapies, vaccination and screening for infections and the use of DMARDs during pregnancy. The recommendations address the selection of disease activity scores, initiation and intensification of therapy using csDMARDs and targeted therapies, and management of RA in patients at risk of reactivation of infectious diseases. These recommendations are discussed in the context of the clinical landscape encountered in the Asia‐Pacific region.
Conclusion
These updated recommendations complement previous APLAR guidelines and aim to support best practice management of RA across the Asia‐Pacific region. They provide a practical framework for national rheumatology associations to develop local guidelines adapted to their specific needs and clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Kitasato University School of Medicine, Sagamihara, Japan.
- Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China.
- Department of Rheumatology, Mandalay General Hospital, Mandalay, Myanmar.
- School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia.
- Department of Rheumatology, National Center for Rheumatic Diseases (NCRD), Kathmandu, Nepal.
- Department of Rheumatology, Bangladesh Medical University, Dhaka, Bangladesh.
ORCID-Profile: Kunihiro Yamaoka, Zhanguo Li, Khin Thin Zar Myo Aung, Paul Bird, Manisha Bhochhibhoya, Minhaj Rahim Choudhury, Debashish Danda, Tsolmon Darisuren, Rudy Hidayat, Nguyen Van Hung, Yuko Kaneko, Wanruchada Katchamart, Manjari Lahiri, Chin Teck Ng, Babur Salim, Keshav Raj Sigdel, Shereen Ch'ng Suyin, Tsutomu Takeuchi, Galymzhan Togizbayev, Evan Vista, Chuanhui Xu, Chak Sing Lau
Förderung
- GlaxoSmithKline
- AbbVie
Zitieren
APA
Yamaoka, K., Li, Z., Aung, K. T. Z. M., Bird, P., Bhochhibhoya, M., Choudhury, M. R., Danda, D., Darisuren, T., Hidayat, R., Hung, N. V., Kaneko, Y., Katchamart, W., Lahiri, M., Ng, C. T., Salim, B., Sigdel, K. R., Suyin, S. C., Takeuchi, T., Togizbayev, G., …, & Lau, C. S. (2026). 2024 Update of the Asia‐Pacific League of Associations for Rheumatology ( APLAR ) Recommendations for Rheumatoid Arthritis Management. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70752
Vancouver
Yamaoka K, Li Z, Aung KTZM, Bird P, Bhochhibhoya M, Choudhury MR, et al. 2024 Update of the Asia‐Pacific League of Associations for Rheumatology ( APLAR ) Recommendations for Rheumatoid Arthritis Management. International Journal of Rheumatic Diseases. 2026. doi:10.1111/1756-185x.70752
BibTeX
@article{Yamaoka2026,
author = {Yamaoka, Kunihiro and Li, Zhanguo and Aung, Khin Thin Zar Myo and Bird, Paul and Bhochhibhoya, Manisha and Choudhury, Minhaj Rahim and Danda, Debashish and Darisuren, Tsolmon and Hidayat, Rudy and Hung, Nguyen Van and Kaneko, Yuko and Katchamart, Wanruchada and Lahiri, Manjari and Ng, Chin Teck and Salim, Babur and Sigdel, Keshav Raj and Suyin, Shereen Ch'ng and Takeuchi, Tsutomu and Togizbayev, Galymzhan and Vista, Evan and Wijeweera, Sandini and Xu, Chuanhui and Lau, Chak Sing},
title = {2024 Update of the Asia‐Pacific League of Associations for Rheumatology ( APLAR ) Recommendations for Rheumatoid Arthritis Management},
journal = {International Journal of Rheumatic Diseases},
year = {2026},
doi = {10.1111/1756-185x.70752}
}
EUVIMED